Logo image of UDMY

UDEMY INC (UDMY) Stock Fundamental Analysis

NASDAQ:UDMY - Nasdaq - US9026851066 - Common Stock - Currency: USD

7.01  +0.07 (+1.01%)

After market: 7.01 0 (0%)

Fundamental Rating

4

UDMY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 72 industry peers in the Diversified Consumer Services industry. UDMY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UDMY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

UDMY had positive earnings in the past year.
In the past year UDMY had a positive cash flow from operations.
In the past 5 years UDMY always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: UDMY reported negative operating cash flow in multiple years.
UDMY Yearly Net Income VS EBIT VS OCF VS FCFUDMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

UDMY's Return On Assets of -10.75% is on the low side compared to the rest of the industry. UDMY is outperformed by 61.11% of its industry peers.
UDMY has a Return On Equity (-32.82%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.75%
ROE -32.82%
ROIC N/A
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
UDMY Yearly ROA, ROE, ROICUDMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

UDMY's Gross Margin of 63.39% is fine compared to the rest of the industry. UDMY outperforms 76.39% of its industry peers.
UDMY's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for UDMY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
UDMY Yearly Profit, Operating, Gross MarginsUDMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

UDMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UDMY has been reduced compared to 1 year ago.
The number of shares outstanding for UDMY has been increased compared to 5 years ago.
There is no outstanding debt for UDMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
UDMY Yearly Shares OutstandingUDMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
UDMY Yearly Total Debt VS Total AssetsUDMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

UDMY has an Altman-Z score of 0.86. This is a bad value and indicates that UDMY is not financially healthy and even has some risk of bankruptcy.
UDMY's Altman-Z score of 0.86 is in line compared to the rest of the industry. UDMY outperforms 48.61% of its industry peers.
There is no outstanding debt for UDMY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.86
ROIC/WACCN/A
WACC9.1%
UDMY Yearly LT Debt VS Equity VS FCFUDMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.29 indicates that UDMY should not have too much problems paying its short term obligations.
UDMY has a Current ratio (1.29) which is comparable to the rest of the industry.
UDMY has a Quick Ratio of 1.29. This is a normal value and indicates that UDMY is financially healthy and should not expect problems in meeting its short term obligations.
UDMY has a Quick ratio (1.29) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
UDMY Yearly Current Assets VS Current LiabilitesUDMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

UDMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.78%, which is quite impressive.
UDMY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.44%.
Measured over the past years, UDMY shows a very strong growth in Revenue. The Revenue has been growing by 23.27% on average per year.
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%1.75%

3.2 Future

Based on estimates for the next years, UDMY will show a very strong growth in Earnings Per Share. The EPS will grow by 53.29% on average per year.
The Revenue is expected to grow by 5.87% on average over the next years.
EPS Next Y176.96%
EPS Next 2Y89.69%
EPS Next 3Y53.29%
EPS Next 5YN/A
Revenue Next Year0.55%
Revenue Next 2Y2.33%
Revenue Next 3Y4.32%
Revenue Next 5Y5.87%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UDMY Yearly Revenue VS EstimatesUDMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
UDMY Yearly EPS VS EstimatesUDMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

5

4. Valuation

4.1 Price/Earnings Ratio

UDMY is valuated quite expensively with a Price/Earnings ratio of 28.04.
UDMY's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of UDMY to the average of the S&P500 Index (27.48), we can say UDMY is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 12.18, the valuation of UDMY can be described as correct.
84.72% of the companies in the same industry are more expensive than UDMY, based on the Price/Forward Earnings ratio.
UDMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.04
Fwd PE 12.18
UDMY Price Earnings VS Forward Price EarningsUDMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of UDMY indicates a somewhat cheap valuation: UDMY is cheaper than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 37.44
EV/EBITDA N/A
UDMY Per share dataUDMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UDMY's earnings are expected to grow with 53.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y89.69%
EPS Next 3Y53.29%

0

5. Dividend

5.1 Amount

No dividends for UDMY!.
Industry RankSector Rank
Dividend Yield N/A

UDEMY INC

NASDAQ:UDMY (7/17/2025, 8:00:02 PM)

After market: 7.01 0 (0%)

7.01

+0.07 (+1.01%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners83.75%
Inst Owner Change0%
Ins Owners3.65%
Ins Owner Change15.95%
Market Cap1.04B
Analysts76.67
Price Target10.22 (45.79%)
Short Float %2.42%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.25%
Min EPS beat(2)18.97%
Max EPS beat(2)49.54%
EPS beat(4)3
Avg EPS beat(4)73.16%
Min EPS beat(4)-262.44%
Max EPS beat(4)486.56%
EPS beat(8)7
Avg EPS beat(8)160.69%
EPS beat(12)11
Avg EPS beat(12)119.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.79%
PT rev (3m)-8.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)29.77%
EPS NY rev (1m)0%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE 28.04
Fwd PE 12.18
P/S 1.32
P/FCF 37.44
P/OCF 23.54
P/B 4.98
P/tB 6.37
EV/EBITDA N/A
EPS(TTM)0.25
EY3.57%
EPS(NY)0.58
Fwd EY8.21%
FCF(TTM)0.19
FCFY2.67%
OCF(TTM)0.3
OCFY4.25%
SpS5.31
BVpS1.41
TBVpS1.1
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.75%
ROE -32.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.39%
FCFM 3.52%
ROA(3y)-16.47%
ROA(5y)-17.55%
ROE(3y)-39.54%
ROE(5y)-143.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.88%
GM growth 5Y5.41%
F-Score7
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 65.37%
Cap/Sales 2.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.86
F-Score7
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)61.78%
Cap/Depr(5y)87.15%
Cap/Sales(3y)2.06%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y176.96%
EPS Next 2Y89.69%
EPS Next 3Y53.29%
EPS Next 5YN/A
Revenue 1Y (TTM)5.44%
Revenue growth 3Y15.11%
Revenue growth 5Y23.27%
Sales Q2Q%1.75%
Revenue Next Year0.55%
Revenue Next 2Y2.33%
Revenue Next 3Y4.32%
Revenue Next 5Y5.87%
EBIT growth 1Y45.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year571.26%
EBIT Next 3Y130.31%
EBIT Next 5Y80.2%
FCF growth 1Y133.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.21%
OCF growth 3YN/A
OCF growth 5YN/A